{"organizations": [], "uuid": "5a49616705d5335701d146186b54c40f635a3a5f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/21/globe-newswire-geron-to-present-at-the-needham-healthcare-conference.html", "country": "US", "domain_rank": 767, "title": "Geron to Present at the Needham Healthcare Conference", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-03-21T14:30:00.000+02:00", "replies_count": 0, "uuid": "5a49616705d5335701d146186b54c40f635a3a5f"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/21/globe-newswire-geron-to-present-at-the-needham-healthcare-conference.html", "ord_in_thread": 0, "title": "Geron to Present at the Needham Healthcare Conference", "locations": [], "entities": {"persons": [{"name": "geron geron", "sentiment": "none"}, {"name": "anna krassowska", "sentiment": "none"}, {"name": "john a. scarlett", "sentiment": "none"}], "locations": [{"name": "menlo park", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "new york", "sentiment": "none"}], "organizations": [{"name": "geron", "sentiment": "negative"}, {"name": "globe newswire", "sentiment": "negative"}, {"name": "geron corporation", "sentiment": "negative"}, {"name": "needham healthcare conference", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "MENLO PARK, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the 17th Annual Needham Healthcare Conference in New York at 4:00 p.m. Eastern Time on Tuesday, March 27, 2018.\nA live webcast of the presentation will be available through the Investor Relations pages of Geronâ€™s website and at http://wsw.com/webcast/needham86/gern/ . Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.\nAbout Geron\nGeron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com .\nCONTACT:\nAnna Krassowska, Ph.D.\nInvestor and Media Relations\n650-473-7765\ninvestor@geron.com\nmedia@geron.com\nSource:Geron Corporation", "external_links": ["http://wsw.com/webcast/needham86/gern/", "https://www.globenewswire.com/NewsRoom/AttachmentNg/58094c6f-e665-402d-a7c0-f39da205b99c"], "published": "2018-03-21T14:30:00.000+02:00", "crawled": "2018-03-21T14:27:26.000+02:00", "highlightTitle": ""}